OverviewRecordsSchemasFilesVersions

Push 29080 records

29,080 records0 files14 MiB total4 types
via nih-clinical-trials/1.0Jun 12, 2026ulv2:1afecdcc134a…ark:12345/ulr1bn5nb6jsbfx.v1.0.0
idstudyIdnamedescriptiontype
NCT00000171-intervention-0NCT00000171Melatonin—DRUG
NCT00000172-intervention-0NCT00000172Galantamine—DRUG
NCT00000173-intervention-0NCT00000173Donepezil—DRUG
NCT00000173-intervention-1NCT00000173Vitamin E—DRUG
NCT00000174-intervention-0NCT00000174Rivastigmine—DRUG
NCT00000176-intervention-0NCT00000176Estrogen—DRUG
NCT00000176-intervention-1NCT00000176Estrogen and Progesterone—DRUG
NCT00000177-intervention-0NCT00000177Estrogen—DRUG
NCT00000178-intervention-0NCT00000178Prednisone—DRUG
NCT00000179-intervention-0NCT00000179Trazodone—DRUG
NCT00000179-intervention-1NCT00000179Haloperidol—DRUG
NCT00001662-intervention-0NCT00001662CX516 (Ampalex)—DRUG
NCT00001917-intervention-0NCT00001917O15—DRUG
NCT00001917-intervention-1NCT00001917[F-18] FP-TZTP—DRUG
NCT00001933-intervention-0NCT00001933Nefiracetam—DRUG
NCT00001972-intervention-0NCT0000197215 O Water—DRUG
NCT00004845-intervention-0NCT00004845Rofecoxib—DRUG
NCT00004845-intervention-1NCT00004845Naproxen—DRUG
NCT00006399-intervention-0NCT00006399Donepezil—DRUG
NCT00006399-intervention-1NCT00006399Estrogen—DRUG
NCT00006399-intervention-2NCT00006399Progesterone—DRUG
NCT00007189-intervention-0NCT00007189Naproxen Sodium (Aleve)—DRUG
NCT00007189-intervention-1NCT00007189Celecoxib (Celebrex)—DRUG
NCT00009191-intervention-0NCT00009191Sertraline [Zoloft]—DRUG
NCT00009204-intervention-0NCT00009204Citalopram [Celexa]—DRUG
NCT00009204-intervention-1NCT00009204Perphenazine [Trilafon]—DRUG
NCT00009217-intervention-0NCT00009217Haloperidol-HaloperidolHaloperidol open label flexible dose 1-5 mg daily for 20 weeks followed by haloperidol double-blind 1-5 mg for 24 weeksDRUG
NCT00009217-intervention-1NCT00009217Haloperidol-PlaceboHaloperidol open-label flexible dose of 1-5 mg for 20 weeks followed by placebo double-blind for 24 weeksDRUG
NCT00010803-intervention-0NCT00010803Ginkgo biloba120mg twice a dayDRUG
NCT00010803-intervention-1NCT00010803PlaceboOne pill twice dailyDRUG
NCT00012857-intervention-0NCT00012857acetaminophen 650 mg qid and placebo qid PRN. The other arm was placebo qid and acetaminophen 650 mg qid PRN—DRUG
NCT00013182-intervention-0NCT00013182social activity—BEHAVIORAL
NCT00013650-intervention-0NCT00013650Cyclophosphamate—DRUG
NCT00013923-intervention-0NCT00013923Nutritional Supplement—DRUG
NCT00015548-intervention-0NCT00015548Olanzapine—DRUG
NCT00015548-intervention-1NCT00015548Quetiapine—DRUG
NCT00015548-intervention-2NCT00015548Risperidone—DRUG
NCT00015548-intervention-3NCT00015548Citalopram—DRUG
NCT00017940-intervention-0NCT00017940Human Nerve Growth Factor—GENETIC
NCT00018278-intervention-0NCT00018278Aricept—DRUG
NCT00018278-intervention-1NCT00018278Exelon—DRUG
NCT00018278-intervention-2NCT00018278Nicoderm Patch—DRUG
NCT00018291-intervention-0NCT00018291Risperidone—DRUG
NCT00018291-intervention-1NCT00018291Gabapentin—DRUG
NCT00018343-intervention-0NCT00018343estrogen—DRUG
NCT00018382-intervention-0NCT00018382rosiglitazone—DRUG
NCT00024531-intervention-0NCT00024531Atorvastatin calcium—DRUG
NCT00034762-intervention-0NCT00034762risperidone—DRUG
NCT00035204-intervention-0NCT00035204galantamine—DRUG
NCT00036114-intervention-0NCT00036114aripiprazole—DRUG
NCT00039702-intervention-0NCT00039702[123] 5-I-A-85380—DRUG
NCT00040378-intervention-0NCT00040378alphatocopherol400 IU dailyDRUG
NCT00040378-intervention-1NCT00040378Selenium200mcg dailyDRUG
NCT00040378-intervention-2NCT00040378Placebo replacement for vitamin E1 placebo pill dailyDRUG
NCT00040378-intervention-3NCT00040378Placebo replacement for Selenium1 placebo pill dailyDRUG
NCT00040443-intervention-0NCT00040443CX516—DRUG
NCT00040443-intervention-1NCT00040443Placebo—DRUG
NCT00041678-intervention-0NCT00041678aripiprazole—DRUG
NCT00042172-intervention-0NCT00042172Donepezil—DRUG
NCT00042172-intervention-1NCT00042172Ginkgo Biloba Extract—DRUG
NCT00046358-intervention-0NCT00046358Lovostatin—DRUG
NCT00046358-intervention-1NCT00046358Ibuprofen—DRUG
NCT00051909-intervention-0NCT00051909LY451395—DRUG
NCT00053599-intervention-0NCT00053599Simvastatin—DRUG
NCT00056225-intervention-0NCT00056225Folate—DRUG
NCT00056225-intervention-1NCT00056225Vitamin B6—DRUG
NCT00056225-intervention-2NCT00056225Vitamin B12—DRUG
NCT00056316-intervention-0NCT00056316Basic EducationParticipants receive 37-page Basic Care Guide (Education Institute, 2001) and bi-weekly telephone calls by a trained staff member.BEHAVIORAL
NCT00056316-intervention-1NCT00056316Behavioral Skills Training: ExperimentalMulticomponent behavioral intervention using 10-session video series (Steffen, et al., 2001) workbook (Steffen, et al., 2001), and weekly telephone coaching sessions.BEHAVIORAL
NCT00056524-intervention-0NCT00056524AVP-923—DRUG
NCT00056628-intervention-0NCT00056628The COGNIShunt® System—DEVICE
NCT00062569-intervention-0NCT00062569Bathing Support Intervention (BSI)Bathing Support Intervention - Review of caregiver current practices and perceptions and care recipient behavioral symptoms associated with bathing with pattern analysis based on observation; skill building for bathing and communication techniques; coaching for implementationBEHAVIORAL
NCT00062569-intervention-1NCT00062569Caregiver reminiscence with coachingBSI plus Reminiscence - BSI as above plus caregiver interview to ascertain pleasant long-term memories (e.g. stories, pictures, music) developed into a "crib sheet" for caregiver use conversationally prior to and during the bathBEHAVIORAL
NCT00063310-intervention-0NCT00063310Leuprolide acetate—DRUG
NCT00065169-intervention-0NCT00065169Celecoxib—DRUG
NCT00065689-intervention-0NCT00065689high-intensity light therapy—DEVICE
NCT00065767-intervention-0NCT00065767Raloxifene—DRUG
NCT00066157-intervention-0NCT00066157Transdermal estradiol50 micrograms (low-dose) or 100 micrograms (high-dose) transdermal 17-ß-estradiol patch, changed every 3 days, for 12 monthsDRUG
NCT00066157-intervention-1NCT00066157Medroxyprogesterone2.5mg tablet daily for 12 monthsDRUG
NCT00066157-intervention-2NCT00066157Placebo PatchTransdermal placebo patch, changed every 3 days, for 12 monthsDRUG
NCT00066157-intervention-3NCT00066157PlaceboPlacebo tablet daily for 12 monthsDRUG
NCT00071721-intervention-0NCT00071721Valproate250mg tablets beginning with one daily for one week, then two daily for one week, then titrated according to body weight and tolerability to achieve 10-12 mg/kg daily for 2 years, followed by a 2-month washoutDRUG
NCT00071721-intervention-1NCT00071721PlaceboPlacebo tablets beginning with one daily and increasing according to weight and perceived tolerability concerns for two years, followed by a 2-month washoutDRUG
NCT00073658-intervention-0NCT00073658Citalopram—DRUG
NCT00073658-intervention-1NCT00073658Risperidone—DRUG
NCT00074529-intervention-0NCT00074529MK0677—DRUG
NCT00076440-intervention-0NCT00076440Leuprolide acetate—DRUG
NCT00082602-intervention-0NCT00082602galantamine ER—DRUG
NCT00083421-intervention-0NCT00083421ONO-2506PO—DRUG
NCT00083590-intervention-0NCT00083590Huperzine A—DRUG
NCT00086138-intervention-0NCT00086138Sertraline (Zoloft)Sertraline: range of 25 to 125 mg per day for 24 weeksDRUG
NCT00086138-intervention-1NCT00086138PlaceboPlacebo designed to mimic sertraline taken daily for 24 weeksDRUG
NCT00087789-intervention-0NCT00087789CERE-110: Adeno-Associated Virus Delivery of NGFCERE-110 2.0 x 10\^10 vg, CERE-110 1.0 x 10\^11 vg, CERE-110 2.0 x 10\^11 vgGENETIC
NCT00088387-intervention-0NCT00088387Divalproex—DRUG
NCT00088387-intervention-1NCT00088387Lithium—DRUG
NCT00089882-intervention-0NCT00089882APOE Genetic susceptibility testing—PROCEDURE
NCT00090116-intervention-0NCT00090116Neramexane—DRUG
NCT00090402-intervention-0NCT00090402Fish OilFish oil capsuleDIETARY_SUPPLEMENT
NCT00090402-intervention-1NCT00090402Lipoic AcidLipoic acid capsuleDIETARY_SUPPLEMENT
NCT00090402-intervention-2NCT00090402Fish Oil PlaceboSoybean oil placebo capsuleOTHER